Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

Amneal Pharmaceuticals, Inc. (AMRX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $4.89 Metrics
OS: 306.3 M -2 % ROE
Market cap: $1.5 B 7 % ROIC
Net debt: $2.59 B 5.9 x Debt/EBITDA
EV: $4.09 B

 
TTM Valuation
EBITDA $438 M 9.3 x EV/EBITDA
EBIT $200 M 20.4 x EV/EBIT
EPS ($0.03)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
Revenues2,212.32,093.71,992.51,626.41,663.01,033.71,018.2866.3
            Revenue growth5.7%5.1%22.5%-2.2%60.9%1.5%17.5% 
Cost of goods sold1,416.51,302.01,329.61,147.2938.8507.5420.8349.6
Gross profit795.8791.7663.0479.2724.2526.2597.5516.7
            Gross margin36.0%37.8%33.3%29.5%43.5%50.9%58.7%59.6%
Selling, general and administrative399.7365.5326.7289.6227.8109.0118.897.2
Research and development195.7201.8179.9188.0194.2171.4179.0136.9
EBITA-81.7358.6277.1-11.3200.2219.8314.3236.2
            EBITA margin-3.7%17.1%13.9%-0.7%12.0%21.3%30.9%27.3%
Amortization of intangibles 172.7175.0144.0144.04.03.7 
EBIT-81.7185.9102.1-155.356.3215.8310.6236.2
            EBIT margin-3.7%8.9%5.1%-9.5%3.4%20.9%30.5%27.3%
Pre-tax income-248.131.4-35.8-220.2-202.7171.3214.8175.6
Income taxes6.711.2-104.4383.3-1.42.05.45.0
            Tax rate 35.7%291.7% 0.7%1.2%2.5%2.8%
Net income-254.810.691.1-361.9-20.90.00.00.0
            Net margin-11.5%0.5%4.6%-22.3%-1.3%0.0%0.0%0.0%
 
Diluted EPS($1.69)$0.07$0.61($2.74)($0.16)   
Shares outstanding (diluted)150.9151.8148.9132.1127.3   
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy